Thyroid Hormones as Renal Cell Cancer Regulators-Reference-Cited by-同舟云学术

Thyroid Hormones as Renal Cell Cancer Regulators

Published:2016-03-13 Issue: Volume:2016 Page:1-8
ISSN:2090-1739
Container-title:Journal of Signal Transduction
language:en
Short-container-title:Journal of Signal Transduction

Author:

Szymański Łukasz¹²³^ORCID,Matak Damian¹⁴,Bartnik Ewa²⁵,Szczylik Cezary¹,Czarnecka Anna M.¹

Affiliation:

1. Department of Oncology, Military Institute of Medicine, Szaserow 128, 04-141 Warsaw, Poland

2. Institute of Genetics and Biotechnology, Faculty of Biology, Warsaw University, Pawinskiego 5a, 02-106 Warsaw, Poland

3. Department of Microwave Safety, Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland

4. School of Molecular Medicine, Medical University of Warsaw, Zwirki i Wigury 61, 02-091 Warsaw, Poland

5. Institute of Biochemistry and Biophysics, Pawinskiego 5a, 02-106 Warsaw, Poland

Abstract

It is known that thyroid hormone is an important regulator of cancer development and metastasis. What is more, changes across the genome, as well as alternative splicing, may affect the activity of the thyroid hormone receptors. Mechanism of action of the thyroid hormone is different in every cancer; therefore in this review thyroid hormone and its receptor are presented as a regulator of renal cell carcinoma.

Funder

Higher Education Juventus

Publisher

Hindawi Limited

Subject

Cell Biology,Cellular and Molecular Neuroscience,Biochemistry

Link

http://downloads.hindawi.com/archive/2016/1362407.pdf

Reference71 articles.

1. Epidemiology and risk factors for kidney cancer

2. Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: From the patient's bed to molecular mechanisms

3. Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma

4. Targeted therapy in metastatic renal carcinoma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine kinase inhibitor–induced hypothyroidism: mechanism and clinical implications;European Journal of Clinical Pharmacology;2024-03-14

3. Uncovering Evidence for Endocrine-Disrupting Chemicals That Elicit Differential Susceptibility through Gene-Environment Interactions;Toxics;2021-04-06

4. Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology 2019;Asia-Pacific Journal of Clinical Oncology;2021-04

5. Thyroid Hormone Nuclear Receptors and Molecular Actions;Endocrinology;2018